EFFECT OF CARBOXYMETHYL-CHITIN-GLUCAN ON CYCLOPHOSPHAMIDE-INDUCED MUTAGENICITY

被引:28
作者
CHORVATOVICOVA, D [1 ]
SANDULA, J [1 ]
机构
[1] SLOVAK ACAD SCI,INST CHEM,BRATISLAVA 84216,SLOVAKIA
来源
MUTATION RESEARCH LETTERS | 1995年 / 346卷 / 01期
关键词
CARBOXYMETHYL-CHITIN-GLUCAN; CYCLOPHOSPHAMIDE; (MICE); MICRONUCLEUS TEST; PERIPHERAL BLOOD RETICULOCYTES; ANTIMUTAGENIC EFFECT;
D O I
10.1016/0165-7992(95)90067-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The effect of high molecular carboxymethyl-chitin-glucan (CMCG), administered either intraperitoneally, intravenously or orally prior to cyclophosphamide injection, on the frequency of micronucleated reticulocytes was evaluated in peripheral blood of female ICR mice. Both intraperitoneal and intravenous administration of CMCG decreased the clastogenic effect of cyclophosphamide. The protective effect of CMCG was concentration dependent, with a higher decrease achieved by 100 mg/kg than by 50 mg/kg body weight. On the other hand, not even five peroral pretreatments with CMCG in the dose of 200 mg/kg body weight during the week prior to simultaneous administration of CMCG and cyclophosphamide induced a decrease of micronucleated reticulocytes in peripheral blood. It is therefore conceivable that CMCG failed to pass through the gastrointestinal tract, probably due to its high molecular weight. The antimutagenic effect of CMCG against cyclophosphamide was manifested by its intraperitoneal and intravenous administration to female ICR mice.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 27 条
[1]   COMPARISON OF SINGLE AND MULTIPLE TREATMENT REGIMENS IN THE MOUSE BONE-MARROW MICRONUCLEUS ASSAY FOR HYDROQUINONE (HQ) AND CYCLOPHOSPHAMIDE (CP) [J].
ADLER, ID ;
KLIESCH, U .
MUTATION RESEARCH, 1990, 234 (3-4) :115-123
[2]  
CHIHARA G, 1982, INT J TISSUE REACT, V4, P207
[3]   PROTECTIVE EFFECT OF SULFOETHYLGLUCAN AGAINST HEXAVALENT CHROMIUM [J].
CHORVATOVICOVA, D ;
KOVACIKOVA, Z ;
SANDULA, J ;
NAVAROVA, J .
MUTATION RESEARCH, 1993, 302 (04) :207-211
[4]   SUPPRESSING EFFECTS OF GLUCAN ON MICRONUCLEI INDUCED BY CYCLOPHOSPHAMIDE IN MICE [J].
CHORVATOVICOVA, D ;
NAVAROVA, J .
MUTATION RESEARCH, 1992, 282 (03) :147-150
[5]  
CHORVATOVICOVA D, 1991, Strahlentherapie und Onkologie, V167, P612
[6]  
DILUZIO NR, 1983, TRENDS PHARMACOL SCI, V8, P344
[7]   PHARMACOKINETIC PROFILE OF RU-41740, A BACTERIAL IMMUNOMODULATOR, IN MICE, RATS, AND MONKEYS [J].
FORTIER, M ;
BONFILS, A ;
ZALISZ, R ;
HEYMAN, M ;
SMETS, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 52 (01) :27-36
[8]   RELATIONSHIP BETWEEN EXPERIMENTAL RESULTS IN MAMMALS AND MAN .1. CYTOGENETIC ANALYSIS OF BONE-MARROW INJURY INDUCED BY A SINGLE DOSE OF CYCLOPHOSPHAMIDE [J].
GOETZ, P ;
SRAM, RJ ;
DOHNALOVA, J .
MUTATION RESEARCH, 1975, 31 (04) :247-254
[9]   THE MICRONUCLEUS ASSAY WITH MOUSE PERIPHERAL-BLOOD RETICULOCYTES USING ACRIDINE ORANGE-COATED SLIDES [J].
HAYASHI, M ;
MORITA, T ;
KODAMA, Y ;
SOFUNI, T ;
ISHIDATE, M .
MUTATION RESEARCH, 1990, 245 (04) :245-249
[10]  
IKUZAWA M, 1988, INT J IMMUNOPHARMACO, V10, P415